Cml Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
Recruiting
- Chronic Myeloid Leukemia
- +3 more
- Antwerpen, Belgium
- +18 more
2022-03-31
Mar 31, 2022N
Active, not recruiting
- CML
- +3 more
- Asciminib add-on
- +2 more
- Augusta, Georgia
- +29 more
2022-02-03
Feb 3, 2022A
Recruiting
- Folate
- +2 more
- Nantong, ChinaAffliated Hospital of Nantong University
2021-12-13
Dec 13, 2021N
Terminated
- CML
- +2 more
- Las Vegas, Nevada
- +2 more
2021-04-28
Apr 28, 2021N
Completed
- CML
- Imatinib
- high-dose imatinib
- Seoul, Korea, Republic ofNovartis Investigational Site
2021-03-09
Mar 9, 2021N
Completed
- CML
- GIST
- Taipei, TaiwanNational Taiwan University Hosptial
2020-08-07
Aug 7, 2020P
Completed
- CML
- 200 Mg capsules of bosutinib in Water solution
- +13 more
- Brussels, BelgiumPfizer Clinical Research Unit
2020-07-08
Jul 8, 2020A
Terminated
- ALL
- +3 more
- Rapamycin + high dose etoposide and cytarabine
- Philadelphia, PennsylvaniaUniversity of Pennsylvania Abramson Cancer Center
2020-04-15
Apr 15, 2020N
Completed
- CML
- Birmingham, Alabama
- +53 more
2020-02-25
Feb 25, 2020N
Completed
- Hodgkin Lymphoma
- +8 more
- Stem cell transplantation
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2019-12-13
Dec 13, 2019A
Completed
- Myeloid Leukemias
- +3 more
- Rapamycin, Mitoxantrone, Etoposide, Cytarabine
- Rapamycin + MEC
- Philadelphia, PennsylvaniaUniversity of Pennsylvania Abramson Cancer Center
2019-07-10
Jul 10, 2019N
Completed
- CML
- +3 more
- Seoul, Korea, Republic ofSt. Mary hospital, Catholic medical center
2017-02-24
Feb 24, 2017U
Completed
- CML
- +6 more
- Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells
- Observation Arm
- Philadelphia, PennsylvaniaUniversity of Pennsylvania
2016-08-17
Aug 17, 2016M
Completed
- Leukemia
- +3 more
- Houston, TexasUT MD Anderson Cancer Center
2016-02-17
Feb 17, 2016S
Completed
- Acute Myeloid Leukemia
- +5 more
- STA-9090 (ganetespib)
- Tampa, Florida
- +2 more
2014-09-17
Sep 17, 2014S
Completed
- AML
- +3 more
- STA-9090 (ganetespib)
- Boston, Massachusetts
- +2 more
2014-09-17
Sep 17, 2014U
Completed
- CML
- +5 more
- San Francisco, CaliforniaUniversity of California San Francisco
2013-08-01
Aug 1, 2013R
Unknown status
- CML
- Treatment modification based on molecular response at 3 months
- Petah tikva, IsraelRabin Medical Center
2013-01-07
Jan 7, 2013C
Completed
- AML
- +2 more
- CYT107 - Recombinant glycosylated human interleukin 7.
- rhIL-7 (CYT107)
- New York, New YorkMemorial Sloan-Kettering Cancer Institute
2012-07-25
Jul 25, 2012D
Completed
- Hematologic Malignancy
- +6 more
- CD+8 T cell depletion
- Boston, Massachusetts
- +1 more
2012-03-15
Mar 15, 2012S
Unknown status
- AML
- +4 more
- fludarabine phosphate, busulfan
- Seoul, Korea, Republic ofDong Hwan Kim
2008-12-29
Dec 29, 2008